Publications & Resources

Although the COVID-19 pandemic has disrupted many aspects of patient care, timely follow-up for patients with potential diagnoses of breast cancer is essential for preventing delayed treatment and care.

On December 9, MLMIC and HANYS will present “2020 Healthcare Law Review,” a webinar on the recent legislative, regulatory and case law developments that impact the provision of healthcare.

Physicians can now turn to new guidance when advising diabetic patients on how to use modern glucose monitoring devices to exercise safely.

Reliable and comprehensive communication between referring and consulting dentists is an important part of providing good patient care and managing risk. Here are brief recommendations to build good communication into the standard office procedure.

The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.

To support policyholders as they navigate the pandemic, MLMIC has assembled a summary of predictive tools and technology to guide management and treatment of COVID-19.

A recent settlement issued by the Office for Civil Rights highlights the importance of adhering to HIPAA’s Right of Access Initiative, a directive requiring covered entities to provide patients, upon request, with timely access to their protected health information.

The coronavirus continues to affect our daily lives, but there is light at the end of the tunnel. Take a look at our FAQs for dentists about the COVID-19 vaccine, trials and what it means for dental practices.

Federal agencies warn of a spike in ransomware targeting hospitals and other healthcare organizations, and at least one health system in New York – St. Lawrence Health System – has reported an attack during this recent burst of cybercrimes.

The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.